Renalytix Plc
RNLXY
$0.205
-$0.016-7.24%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.03M | -33.46M | -37.49M | -41.85M | -43.81M |
| Total Depreciation and Amortization | 197.00K | 264.00K | 224.00K | 285.00K | 345.00K |
| Total Amortization of Deferred Charges | 100.00K | 100.00K | 200.00K | 200.00K | 160.00K |
| Total Other Non-Cash Items | 5.49M | 6.51M | 4.07M | 3.89M | 4.21M |
| Change in Net Operating Assets | -2.20M | -3.53M | 2.07M | 1.32M | 2.62M |
| Cash from Operations | -24.44M | -30.11M | -30.92M | -36.16M | -36.47M |
| Capital Expenditure | -4.00K | -4.00K | -3.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 59.00K | 64.00K | 0.00 |
| Cash from Investing | -4.00K | -4.00K | 56.00K | 64.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -600.00K | -1.66M | -1.58M | -3.19M | -3.18M |
| Issuance of Common Stock | 13.65M | 13.63M | 5.31M | 20.53M | 20.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.71M | -1.72M | -1.37M | -996.00K | -996.00K |
| Cash from Financing | 11.34M | 10.25M | 2.36M | 16.35M | 16.27M |
| Foreign Exchange rate Adjustments | 127.00K | -137.00K | 176.00K | 1.55M | 3.06M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.98M | -20.00M | -28.32M | -18.20M | -17.15M |